114 related articles for article (PubMed ID: 16214418)
1. DNA repair inhibition: a selective tumour targeting strategy.
Madhusudan S; Hickson ID
Trends Mol Med; 2005 Nov; 11(11):503-11. PubMed ID: 16214418
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
[TBL] [Abstract][Full Text] [Related]
3. Targeting the DNA damage response in oncology: past, present and future perspectives.
Basu B; Yap TA; Molife LR; de Bono JS
Curr Opin Oncol; 2012 May; 24(3):316-24. PubMed ID: 22476188
[TBL] [Abstract][Full Text] [Related]
4. Emerging cancer therapeutic opportunities target DNA-repair systems.
Ding J; Miao ZH; Meng LH; Geng MY
Trends Pharmacol Sci; 2006 Jun; 27(6):338-44. PubMed ID: 16697054
[TBL] [Abstract][Full Text] [Related]
5. Gallic acid provokes DNA damage and suppresses DNA repair gene expression in human prostate cancer PC-3 cells.
Liu KC; Ho HC; Huang AC; Ji BC; Lin HY; Chueh FS; Yang JS; Lu CC; Chiang JH; Meng M; Chung JG
Environ Toxicol; 2013 Oct; 28(10):579-87. PubMed ID: 21887735
[TBL] [Abstract][Full Text] [Related]
6. Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family.
Finlay MR; Griffin RJ
Bioorg Med Chem Lett; 2012 Sep; 22(17):5352-9. PubMed ID: 22835870
[TBL] [Abstract][Full Text] [Related]
7. DNA repair inhibition and cancer therapy.
Martin NM
J Photochem Photobiol B; 2001 Oct; 63(1-3):162-70. PubMed ID: 11684463
[TBL] [Abstract][Full Text] [Related]
8. Development of a high-content high-throughput screening assay for the discovery of ATM signaling inhibitors.
Bardelle C; Boros J
J Biomol Screen; 2012 Aug; 17(7):912-20. PubMed ID: 22653913
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
Bryant HE; Helleday T
Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
[TBL] [Abstract][Full Text] [Related]
10. Proteomics success story. Novel biomarkers for DNA damage response pathways: insights and applications for cancer therapy.
O'Connor M
Proteomics; 2006 Sep; 6 Suppl 2():69-71. PubMed ID: 17031802
[No Abstract] [Full Text] [Related]
11. Sodium salicylate acts through direct inhibition of phosphoinositide 3-kinase-like kinases to modulate topoisomerase-mediated DNA damage responses.
Fan JR; Huang TH; Wen CY; Shen TL; Li TK
Eur J Pharmacol; 2010 Jul; 638(1-3):13-20. PubMed ID: 20406630
[TBL] [Abstract][Full Text] [Related]
12. Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells.
Chen YY; Chiang SY; Lin JG; Yang JS; Ma YS; Liao CL; Lai TY; Tang NY; Chung JG
Anticancer Res; 2010 Mar; 30(3):945-51. PubMed ID: 20393018
[TBL] [Abstract][Full Text] [Related]
13. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the ATR- and ATM-dependent checkpoint responses in cell cycle arrest evoked by pierisin-1.
Shiotani B; Kobayashi M; Watanabe M; Yamamoto K; Sugimura T; Wakabayashi K
Mol Cancer Res; 2006 Feb; 4(2):125-33. PubMed ID: 16513843
[TBL] [Abstract][Full Text] [Related]
15. DNA repair factors and telomere-chromosome integrity in mammalian cells.
Hande MP
Cytogenet Genome Res; 2004; 104(1-4):116-22. PubMed ID: 15162024
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription.
Khalil HS; Tummala H; Hupp TR; Zhelev N
Exp Biol Med (Maywood); 2012 Jun; 237(6):622-34. PubMed ID: 22728709
[TBL] [Abstract][Full Text] [Related]
17. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
18. Targeting DNA repair as a promising approach in cancer therapy.
Damia G; D'Incalci M
Eur J Cancer; 2007 Aug; 43(12):1791-801. PubMed ID: 17588740
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation.
Sun Y; Jiang X; Chen S; Price BD
FEBS Lett; 2006 Aug; 580(18):4353-6. PubMed ID: 16844118
[TBL] [Abstract][Full Text] [Related]
20. Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition.
Aguilar-Quesada R; Muñoz-Gámez JA; Martín-Oliva D; Peralta A; Valenzuela MT; Matínez-Romero R; Quiles-Pérez R; Menissier-de Murcia J; de Murcia G; Ruiz de Almodóvar M; Oliver FJ
BMC Mol Biol; 2007 Apr; 8():29. PubMed ID: 17459151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
